| The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs A Akinc, MA Maier, M Manoharan, K Fitzgerald, M Jayaraman, S Barros, ... Nature Nanotechnology 14 (12), 1084-1087, 2019 | 1296 | 2019 |
| Smart cancer nanomedicine R van der Meel, E Sulheim, Y Shi, F Kiessling, WJM Mulder, T Lammers Nature Nanotechnology 14 (11), 1007-1017, 2019 | 1081 | 2019 |
| The current landscape of nucleic acid therapeutics JA Kulkarni, D Witzigmann, SB Thomson, S Chen, BR Leavitt, PR Cullis, ... Nature Nanotechnology 16 (6), 630-643, 2021 | 992 | 2021 |
| The EPR effect and beyond: Strategies to improve tumor targeting and cancer nanomedicine treatment efficacy Y Shi, R van der Meel, X Chen, T Lammers Theranostics 10 (17), 7921-7924, 2020 | 663 | 2020 |
| PEGylated and targeted extracellular vesicles display enhanced cell specificity and circulation time SAA Kooijmans, LAL Fliervoet, R van der Meel, M Fens, HFG Heijnen, ... Journal of Controlled Release 224, 77-85, 2016 | 555 | 2016 |
| On the formation and morphology of lipid nanoparticles containing ionizable cationic lipids and siRNA JA Kulkarni, MM Darjuan, JE Mercer, S Chen, R Van Der Meel, ... ACS nano 12 (5), 4787-4795, 2018 | 502 | 2018 |
| Extracellular vesicles as drug delivery systems: lessons from the liposome field R van der Meel, MHAM Fens, P Vader, WW Van Solinge, ... Journal of controlled release 195, 72-85, 2014 | 500 | 2014 |
| Lipid nanoparticles enabling gene therapies: from concepts to clinical utility JA Kulkarni, PR Cullis, R Van Der Meel Nucleic acid therapeutics 28 (3), 146-157, 2018 | 496 | 2018 |
| Ligand-targeted particulate nanomedicines undergoing clinical evaluation: current status R van der Meel, LJC Vehmeijer, RJ Kok, G Storm, EVB van Gaal Advanced Drug Delivery Reviews, 1284-1298, 2013 | 484 | 2013 |
| Lipid Nanoparticle Technology for Clinical Translation of siRNA Therapeutic JA Kulkarni, D Witzigmann, S Chen, PR Cullis, R van der Meel Accounts of Chemical Research 52 (9), 2435 - 2444, 2019 | 432 | 2019 |
| Lipid nanoparticle technology for therapeutic gene regulation in the liver D Witzigmann, JA Kulkarni, J Leung, S Chen, PR Cullis, R van der Meel Advanced drug delivery reviews, 2020 | 311 | 2020 |
| State‐of‐the‐art design and rapid‐mixing production techniques of lipid nanoparticles for nucleic acid delivery MJW Evers, JA Kulkarni, R van der Meel, PR Cullis, P Vader, ... Small methods 2 (9), 1700375, 2018 | 293 | 2018 |
| Complete Regression of Xenograft Tumors upon Targeted Delivery of Paclitaxel via Π–Π Stacking Stabilized Polymeric Micelles Y Shi, R Van Der Meel, B Theek, E Oude Blenke, EHE Pieters, ... ACS nano 9 (4), 3740-3752, 2015 | 215 | 2015 |
| Dexamethasone nanomedicines for COVID-19 T Lammers, AM Sofias, R Van der Meel, R Schiffelers, G Storm, F Tacke, ... Nature nanotechnology 15 (8), 622-624, 2020 | 187 | 2020 |
| Downregulation of EGFR by a novel multivalent nanobody-liposome platform S Oliveira, RM Schiffelers, J van der Veeken, R van der Meel, ... Journal of Controlled Release 145 (2), 165-175, 2010 | 175 | 2010 |
| Cancer nanomedicines: oversold or underappreciated? R van der Meel, T Lammers, WE Hennink Expert Opinion on Drug Delivery 14 (1), 1-5, 2016 | 159 | 2016 |
| Reprint of" Nanobody—Shell functionalized thermosensitive core-crosslinked polymeric micelles for active drug targeting" M Talelli, CJF Rijcken, S Oliveira, R van der Meel, PMPB en Henegouwen, ... Journal of controlled release 153 (1), 93-102, 2011 | 140 | 2011 |
| Nanobody-albumin nanoparticles (NANAPs) for the delivery of a multikinase inhibitor 17864 to EGFR overexpressing tumor cells I Altintas, R Heukers, R van der Meel, M Lacombe, M Amidi, ... Journal of Controlled Release 165 (2), 110-118, 2013 | 128 | 2013 |
| Fusion-Dependent Formation of Lipid Nanoparticles Containing Macromolecular Payloads JA Kulkarni, D Witzigmann, J Leung, R van der Meel, J Zaifman, ... Nanoscale 11, 9023-9031, 2019 | 127 | 2019 |
| Engineering cytokine therapeutics J Deckers, T Anbergen, A Hokke, A de Dreu, DP Schrijver, K de Bruin, ... Nature Reviews Bioengineering 1, 286–303, 2023 | 116 | 2023 |
Raymond SchiffelersProfessor of Nanomedicine, CDL Research, University Medical Center UtrechtVerified email at umcutrecht.nl
